Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript February 28, 2024
Standard BioTools Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.13. LAB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day, everyone, and welcome to Standard BioTools, Inc. Fourth Quarter and Full Year 2023 Financial Results Conference Call. As a reminder, this conference is being recorded....
